Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Role of Trans-Catheter Prostatic Artery Embolization in Management of Benign Prostatic Hyperplasia
Home
Publications
Role of Trans-Catheter Prostatic Artery Embolization in Management of Benign Prostatic Hyperplasia
Role of Trans-Catheter Prostatic Artery Embolization in Management of Benign Prostatic Hyperplasia
Authors:
MM
Momtaz Thabet Allam Mohammad
Momtaz Thabet Allam Mohammad
AA
Abd Al Kariem Hassan Abd Allah
Abd Al Kariem Hassan Abd Allah
MO
Moustafa Hashem Mahmoud Othman
Moustafa Hashem Mahmoud Othman
HS
Hany Mohammed Abd El Hakeem Seif
Hany Mohammed Abd El Hakeem Seif
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
26 April 2017
conference paper
Published by
Georg Thieme Verlag KG
in
The Arab Journal of Interventional Radiology
Vol. 01
(03)
,
P401
DOI:
10.1055/s-0041-1729809
Abstract
Background: To evaluate the efficacy and safety of prostatic artery embolization as a line of treatment for benign prostatic hyperplasia in patient with moderate to severe lower urinary tract symptoms (LUTS) secondary to BPH after failure of medical treatment. Methods: Twenty patients included in this study and their ages ranged from 43-93 years (mean 68.3 y). All patients complained of moderate to severe LUTS secondary to benign prostatic enlargement. All patients underwent prostatic artery embolization (unilateral n = 5 and bilateral n = 15). The embolizing material used is PVA ranged from (45-250). Patients were followed up using international prostate symptom score (IPSS), prostate volume, quality of life (QOL) and peak flow rate (Qmax). Results: Nineteen patients show IPSS reduction by 0.0-86% (mean 73.68% +/- 16.8), prostate volume reduction by 14.6-41.5% (mean 26.16% +/- 7.8), QOL improvement by 0.0-100% (mean 81.3% +/- 24.34) and Qmax improvement by 36.1-80.5% (mean 62.6% +/- 14.29) after one and three months follow up. Clinical improvement was +/- 95%. One patient shows clinical failure after successful bilateral prostatic artery embolization. No deaths. Minor complications as hematuria and blood in stool occurred in 10% (2 cases) and were self-limited. Conclusions: Prostatic artery embolization is safe and effective line of treatment for patients with moderate to severe LUTS secondary to benign prostatic enlargement after failure of medical treatment. It has low morbidity, good short-term symptomatic control associated with prostate volume reduction and quality of life improvement. Publication Date: 26 April 2021 (online) © 2017. The Arab Journal of Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
Keywords
QUALITY OF LIFE
EFFICACY
EMBOLIZATION
LUTS SECONDARY
VOLUME REDUCTION
PROSTATIC ENLARGEMENT
MEDICAL TREATMENT
SEVERE LUTS
Related articles
Scroll to top